Inogen, Inc.·Healthcare

Inogen (INGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces the Appointment of Vafa Jamali to Board of Directors.

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference.

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth.

Inogen (INGN) reported earnings 30 days ago. What's next for the stock?
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Healthcare
Medical - Devices
766
2014-02-14
1.71